THE CORRELATION BETWEEN SERUM SODIUM LEVELS AND THE SEVERITY OF CIRRHOSIS OF LIVER AND ITS COMPLICATIONS

RUPA PRADHAN; DIPTIMAYEE  TRIPATHY; SIBANARAYAN  JALI

doi:10.22159/ajpcr.2024.v17i6.50762

Authors

RUPA PRADHAN Department of General Medicine, MKCG Medical College, Berhampur, Odisha, India https://orcid.org/0009-0004-1513-9379
DIPTIMAYEE TRIPATHY Department of General Medicine, KIMS Medical College, Bhubaneswar, Odisha, India
SIBANARAYAN JALI Department of General Medicine, MKCG Medical College, Berhampur, Odisha, India

DOI:

https://doi.org/10.22159/ajpcr.2024.v17i6.50762

Keywords:

Cirrhosis of liver, Hyponatremia, Complications

Abstract

Objective: The study aimed to assess the incidence of hyponatremia in cirrhosis of the liver and to evaluate the association between serum sodium levels and the severity of cirrhosis and its complications.

Methods: Data on inpatients with cirrhosis of the liver were collected on the date of admission. The serum sodium levels on day 1 and the presence of complications and their severity in 100 patients were analyzed.

Results: The incidence of dilutional hyponatremia, which was subdivided into three groups (mmol/L): A-≤130, B-131-135, and C-≥136, were 55%, 25%, and 20%, respectively. The severity of liver cirrhosis was assessed using the CTP score and the MELD score, with a higher score seen in Group A (p=0.011 and p=0.012), respectively. Furthermore in group A, higher grades of complications were seen: grade 3/gross ascites (p=0.001), grade lll/lV hepatic encephalopathy (p=0.007), spontaneous bacterial peritonitis (p=0.049), and hepatorenal syndrome (p=0.022). Even in group B with s.Na+level 131–135 mmol/L, the development of complications was no less common.

Conclusion: Serum sodium levels must be closely monitored in cirrhotic patients as they suggest the possibility of a potentially negative impact on the clinical course of the disease.

Downloads

Download data is not yet available.

References

Arora G, Keeffe EB. Management of chronic liver failure until liver transplantation. Med Clin N Am. 2008;839-60, ix. doi: 10.1016/j. mcna.2008.03.006, PMID: 18570945

Gines P, Guevara M. Hyponatremia in cirrhosis: Pathogenesis, clinical significance, and management. Hepatology. 2008 Sep;48(3):1002-10. doi: 10.1002/hep.22418, PMID: 18671303

Agarwal S, Thakur MB. The association between serum sodium levels and the severity of cirrhosis of liver and its complications. Indian J Appl Res. 2019;9(8). doi: 10.36106/ijar

Shah V. Molecular mechanisms of increased intrahepatic resistance in portal hypertension. J Clin Gastroeneterol. 2007;41(3):S259-61. doi: 10.1097/MCG.0b013e318150d0e1, PMID: 17975474

Treiber G, Csepregi A, Malfertheiner P. The pathophysiology of portal hypertension. Dig Dis. 2005;23:6-10. doi: 10.1159/000084720, PMID:15920320

Angeli P, Wong F, Watson H, Gines P, CAPPS Investigators. Hyponatremia in cirrhosis: Results of a population survey. Hepatology. 2006;44:1535-42. doi: 10.1002/hep.21412, PMID: 17133458

Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identifypatients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40:802-10. doi: 10.1002/hep.20405, PMID: 15382176

Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quintó L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol. 2001;34:46-52. doi: 10.1016/s0168- 8278(00)00011-8, PMID: 11211907

Ripoll C, Banares R, Rincon D, Catalina MV, Lo Iacono O, Salcedo M, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era. Hepatology. 2005;42:793-801. doi: 10.1002/hep.20871, PMid: 16175621

Dooley JS, Lok AS, Burroughs AK, Heathcole EJ. Sherlock’s Diseases of the Liver and Biliary System. 12th ed. New Jersey: Wiley-Blackwell Publications; 2011.

Feldman M, Friedman LS, Brandt LJ, Sleisenger and Fordtran’s Gastrointestinal and Liver Diseases: Pathophysiology/Diagnosis and Management. 9th ed. Philadelphia, PA: Saunders, Elsevier; 2010.

Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: Part l. Diagnosis and evaluation. Am Fam Physicians. 2006;74:756-62.

Eisenberg RL. Gastrointestinal Radiology-a Pattern approach. 3rd ed. Philadelphia, PA: Lipincott-Raven Publishers; 1996.

Gines P, Angeli P, Lenz K, Moller S, Moore K, Moreau R, et al. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397-417. PMID: 20633946. DOI: 10.1016/j.jhep.2010.05.004.

Munoz SJ. Hepatic encephalopathy. Med Clin N Am. 2008;92:795-812, viii. doi: 10.1016/j.mcna.2008.03.009, PMID: 18570943

Guevara M, Gines P. Hyponatremia in liver cirrhosis: Pathogenesis and treatment. Endocrinol Nutr. 2010 May;57(2):15-21. doi: 10.1111/j.1478- 3231.2010.02293.x, PMID: 20602681

Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581-9. doi: 10.1056/NEJM200005253422107, PMID: 10824078

Gines P, Berl T, Bernardi M, Bichet DG, Hamon G, Jimenez W, et al. Hyponatremia in cirrhosis: From pathogenesis to treatment. Hepatology. 1998;28:851-64. doi: 10.1002/hep.510280337, PMID: 9731583

Kim JH, Lee JS, Lee SH. The association between the serum sodium level and the severity of complications in liver cirrhosis. Korean J Intern Med. 2009 Jun;24(2):106-12. doi: 10.3904/kjim.2009.24.2.106, PMID: 19543488 PMCID: PMC2698618

Moini M, Hoseini-Asl MK, Taghavi SA, Sagheb MM, Nikeghbalian S, Salahi H, et al. Hyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantation. Clin Transplant. 2011;25(4):638-45. doi: 10.1111/j.1399-0012.2010.01350.x, PMID: 21077951

Zameer M, Kunnathil SG, Sathar SA, Kumar A, Sreesh S, Narayanan P, et al. Association between serum sodium level and severity of complications of cirrhosis. 2013;3(1):S91-2. doi: 10.1016/j. jceh.2013.02.231

Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl. 2005;11:336-43. doi: 10.1002/lt.20329, PMID: 15719386

Shaikh S, Mal G, Khalid S, Baloch GH, Akbar Y. Frequency of hyponatremia and its influence on liver cirrhosis-related complications. J Pak Med Assoc. 2010;60:116-20. PMID: 20209698

Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis. 2000;32:605-10. doi: 10.1016/s1590- 8658(00)80844-0, PMID: 11142560

Maher M, Yosef TM, Saabry AI, Saleh SA, Alkady H. Hyponatremia and zinc deficiency as a risk factor for hepatic encephalopathy in cirrhotic patients deficiency as a risk factor for hepatic encephalopathy in cirrhotic patients. Life Sci J. 2013;10(3):1493-500.

Porcel A, Diaz F, Rendon P, Macias M, Martin-Herrera L, Giron- Gonzalez JA, et al. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med. 2002;162:323-8. doi: 10.1001/ archinte.162.3.323, PMID: 11822925